Giffin Daughtridge, MD
Co-founder & CEO
Giffin is the co-founder and CEO of UrSure Inc., which makes diagnostic tests aimed at monitoring and improving medication adherence. To date, UrSure has raised $1.9M in nondilutive funding by winning the Harvard Business School’s New Venture Competition, the Harvard President’s Innovation Challenge, and receiving an NIH Small Business Innovation Research Phase I and II Grant. Giffin holds an MD from the Perelman School of Medicine at the University of Pennsylvania and an MPA from the Harvard Kennedy School where he was a Zuckerman Fellow in the Center for Public Leadership. He has been a Fulbright research scholar to Colombia, and he was recently named to the 2018 Forbes 30 under 30 list for healthcare.